Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure?

Merck & Co Inc MRK will be reporting its first-quarter earnings on Thursday before the market opens. Wall Street expects earnings per share of $2.14 and revenue of$15.33 billion.The stock is down a painful 38.04% over the past year and has dropped 20.73% year-to-date. Even in the past month, it’s off by 14.85%, making it one of the more bruised names among Big Pharma peers.Let's look at what the charts indicate for Merck stock and how it currently maps against Wall Street estimates.Read Also: Gilead Cancer ...